Global Synthetic Biology Market 2014-2018

News provided by

Research and Markets

28 Jul, 2014, 16:16 BST

DUBLIN, July 28, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Synthetic Biology Market 2014-2018" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

The term synthetic biology covers the designing and engineering of completely new biological parts, devices, and organisms as well as the redesigning of natural biological systems that provide improved and desirable functions. It is considered to be a form of extreme genetic engineering because it not only alters existing metabolic pathways, but also creates new ones. The engineered biological systems can be used to manipulate chemicals, fabricate materials and structures, produce energy, provide GM food, improve the efficiency of drugs and vaccines, and maintain a sustainable environment.

The analysts forecast the Global Synthetic Biology market will grow at a CAGR of 33.8 percent over the period 2013-2018.

The Global Synthetic Biology market can be categorized on the basis of technology into four segments: Genome Engineering. DNA Sequencing, Bioinformatics, and Biological Components and Integrated Systems.

Key Topics Covered:

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

04. Market Research Methodology

05. Introduction

06. Market Landscape

07. Market Segmentation by Technology

08. Market Segmentation by Product

09. Market Segmentation by Applications

10. Geographical Segmentation

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

19. Key Vendor Analysis

20. Other Reports in this Series

Companies Mentioned:

  • Amyris Inc.
  • E. I. du Pont de Nemours and Co.
  • Thermo Fisher Scientific Inc.
  • Synthetic Genomics Inc.
  • Algenol Biofuels Inc.
  • ATG:biosynthetics GmbH
  • Bayer AG
  • Bioneer Corp.
  • Biosearch Technologies Inc.
  • Bristol-Myers Squibb Co.
  • CBC Comprehensive Biomarker Center GmbH
  • Cobalt Technologies
  • Evolva Holdings SA
  • Exxon Mobil Corp.
  • GeneWorks Pty Ltd.
  • Genomatica Inc.
  • Gevo Inc.
  • Ginkgo Bioworks
  • Green Biologics Ltd.
  • New England Biolabs Inc.
  • OriGene Technologies Inc.
  • REG Life Sciences LLC
  • Royal DSM
  • Synthorx Inc.

For more information visit http://www.researchandmarkets.com/research/dtxhfz/global_synthetic

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets